Rainbow Children's Medicare Limited (RAINBOW.BO)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INR bn | 7 | 7 | 10 | 12 | 13 | 15 | 17 | 18 |
| Operating profit | INR bn | 4 | 4 | ||||||
| Net profit | INR bn | 1 | 0 | 1 | 2 | 2 | 2 | 3 | 3 |
| EPS reported | INR | 27.41 | 28.10 | ||||||
| Operating cashflow per share | INR | 34.83 | 20.45 | ||||||
| Capex per share | INR | 21.32 | 29.78 | ||||||
| FCF per share | INR | 13.51 | -9.33 | ||||||
| Free cash flow | INR bn | 1 | -1 | ||||||
| Net debt | INR bn | -4 | -5 | ||||||
| Book value equity | INR bn | 16 | 17 | ||||||
| Book value per share | INR | 162.3 | 163.8 | ||||||
| Number of shares | m | 101.54 | 101.57 | ||||||
| DPS (TTM paid) | INR | 3.50 | 3.50 |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 41.70 | 50.11 | ||||||
| P/B LTM | x | 7.17 | 8.38 | ||||||
| P/S LTM | x | 6.79 | 7.66 | ||||||
| P/FCF LTM | x | 86.07 | -147.30 | ||||||
| EV/EBITDA LTM | x | 18.35 | 24.59 | ||||||
| EV/Sales LTM | x | 6.15 | 9.25 | ||||||
| Earnings Yield LTM | % | +4.06% | +2.00% | ||||||
| FCF Yield | % | +1.16% | -0.68% | ||||||
| Quality | |||||||||
| ROE | % | +16.89% | +18.22% | ||||||
| ROIC | % | +11.82% | +11.82% | ||||||
| Operating margin | % | +23.11% | +23.11% | ||||||
| Gross margin | % | +39.52% | +39.52% | ||||||
| FCF/Sales | % | +8.06% | -5.56% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +14.97% | +31.43% | ||||||
| Sales Growth YoY | % | +12.35% | +40.34% | ||||||
| Net Income Growth YoY | % | +14.34% | +31.52% | ||||||
| FCF Growth | % | -45.11% | - | ||||||
| Operating Profit Growth | % | -42.07% | -29.94% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.26% | +0.24% | ||||||
| Dividend Growth | % | +16.86% | -41.67% | ||||||
| Payout Ratio | % | +10.95% | +10.95% | ||||||
| FCF/Debt | x | 0.15 | - | ||||||
| Net Debt/EBITDA | x | 1.46 | 1.46 | ||||||
| EBIT/Net interest | x | 5.07 | 5.07 | ||||||
| Net debt/market cap | % | +0.22% | +0.17% | ||||||
| Net debt/Equity | x | -0.25 | -0.29 | ||||||
| Gross debt/equity | x | 0.54 | 0.00 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Rainbow Children's Medicare Limited manages a network of specialized hospitals across India, focusing on pediatric care, obstetrics, and gynecology. For children, the company offers a comprehensive suite of medical and surgical specialties. This includes general pediatrics, advanced critical care (neonatal and pediatric intensive care units), and a broad spectrum of surgical interventions such as neurosurgery, urology, cranio-maxillofacial surgery, and plastic surgery. Specific medical sub-specialties provided cover gastroenterology and liver diseases, haematology and oncology, pulmonology, endocrinology, nephrology, cardiology, orthopaedics, ophthalmology, ENT, dermatology, allergy, and rheumatology. Support services extend to psychology, nutrition, psychiatry, anaesthesia and pain management, radiology, physiotherapy and rehabilitation, speech and language therapy, and occupational therapy. Moreover, specialized programs are available for bone marrow and kidney transplants, cochlear implants, genetic and metabolic disorders, infectious diseases, developmental and behavioral paediatrics, and cerebral palsy, all backed by comprehensive laboratory diagnostics. Regarding women's health, services span comprehensive obstetrics and gynaecology. This encompasses all stages of pregnancy, from pre-pregnancy checkups and high-risk pregnancy management to painless delivery options, childbirth preparation, vaginal birth after caesarean (VBAC), and crucial breastfeeding support, along with newborn care. General gynaecological services include well-women checkups, urogynaecology, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, women's nutrition, and diabetology. For fertility, Rainbow Children's Medicare offers a full range of assisted reproductive technologies (ART) and related treatments. These include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intracytoplasmic morphologically selected sperm injection (IMSI), ovulation induction, intrauterine insemination (IUI), and assisted hatching. Comprehensive services also cover fertility investigations, cryopreservation, donor programs for sperm, oocytes, and embryos, reproductive surgery, andrology and urology, and pre-conception counselling. Established in 1998, Rainbow Children's Medicare Limited has its headquarters in Hyderabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Rainbow Children's Medicare Limited (RAINBOW.BO)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Rainbow Children's Medicare Limited manages a network of specialized hospitals across India, focusing on pediatric care, obstetrics, and gynecology. For children, the company offers a comprehensive suite of medical and surgical specialties. This includes general pediatrics, advanced critical care (neonatal and pediatric intensive care units), and a broad spectrum of surgical interventions such as neurosurgery, urology, cranio-maxillofacial surgery, and plastic surgery. Specific medical sub-specialties provided cover gastroenterology and liver diseases, haematology and oncology, pulmonology, endocrinology, nephrology, cardiology, orthopaedics, ophthalmology, ENT, dermatology, allergy, and rheumatology. Support services extend to psychology, nutrition, psychiatry, anaesthesia and pain management, radiology, physiotherapy and rehabilitation, speech and language therapy, and occupational therapy. Moreover, specialized programs are available for bone marrow and kidney transplants, cochlear implants, genetic and metabolic disorders, infectious diseases, developmental and behavioral paediatrics, and cerebral palsy, all backed by comprehensive laboratory diagnostics. Regarding women's health, services span comprehensive obstetrics and gynaecology. This encompasses all stages of pregnancy, from pre-pregnancy checkups and high-risk pregnancy management to painless delivery options, childbirth preparation, vaginal birth after caesarean (VBAC), and crucial breastfeeding support, along with newborn care. General gynaecological services include well-women checkups, urogynaecology, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, women's nutrition, and diabetology. For fertility, Rainbow Children's Medicare offers a full range of assisted reproductive technologies (ART) and related treatments. These include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intracytoplasmic morphologically selected sperm injection (IMSI), ovulation induction, intrauterine insemination (IUI), and assisted hatching. Comprehensive services also cover fertility investigations, cryopreservation, donor programs for sperm, oocytes, and embryos, reproductive surgery, andrology and urology, and pre-conception counselling. Established in 1998, Rainbow Children's Medicare Limited has its headquarters in Hyderabad, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free